3:29 PM
 | 
Mar 13, 2018
 |  BC Extra  |  Financial News

Perceptive leads Crinetics' $63.5M series B

Endocrine disease company Crinetics Pharmaceuticals Inc. (San Diego, Calif.) raised $63.5 million in a series B round led by Perceptive Advisors. New investors RA Capital and OrbiMed Advisors also participated, as...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >